Hepatitis Treatment

Hepatitis Care

Explore hepatitis-care medicines by active ingredient and combination. Treatment selection and duration are clinical decisions, so sourcing proceeds only against appropriate product details and any required prescription or supporting documents.

What we review before supply

• Treatment choice must come from the treating clinician.
• Combination products and strengths are verified before sourcing.
• Import and prescription documentation depends on destination rules.

Hepatitis Care catalogue

• Sofosbuvir 400mg (Hepcinat)

  Direct-acting antiviral for chronic Hepatitis C. 12-week course exported with verified prescription.

• Sofosbuvir + Velpatasvir 400/100mg (Velpanat)

  Pan-genotypic single-tablet regimen covering all six Hepatitis C genotypes.

• Ledipasvir + Sofosbuvir 90/400mg (Ledifos)

  Fixed-dose combination for Hepatitis C genotype 1. Shipped with batch COA on request.

• Tenofovir Alafenamide 25mg (Tafnat)

  Newer tenofovir prodrug for chronic Hepatitis B with improved kidney and bone safety profile.

Product information is for catalogue and sourcing purposes and is not medical advice. A prescription and destination-specific approval may be required.